SPR Therapeutics is a medical device company that is commercializing pain treatments utilizing its proprietary peripheral nerve stimulation (PNS) products. We are developing a pipeline of neurostimulation pain therapies that will exploit the same physiologic mechanism of action, proprietary technology, and clinical approach. The first product to be commercialized is the SMARTPATCH™ PNS System, which is a short-term, minimally invasive system that is simple to deliver and can be used for up to 30 days to stimulate electrically a peripheral nerve to relieve pain. SPR Therapeutics was formed in January, 2010 as a portfolio company of NDI Medical, LLC.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/24/12 | $2,200,000 | Series A |
NDI Medical | undisclosed |
| 01/09/13 | $5,000,000 | Series A |
NDI Healthcare Fund Public Square Partners | undisclosed |
| 09/12/17 | $25,000,000 | Series C |
Frontcourt Ventures | undisclosed |
| 02/01/24 | $85,000,000 | Venture Debt & Equity |
Mutual Capital Partners RC Capital Revelation Partners SLR Capital Partners | undisclosed |
